Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Nov 21, 2022
Open Peer Review Period: Nov 21, 2022 - Jan 16, 2023
Date Accepted: Jun 25, 2023
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Assessing Serious Spinal Pathology Using Bayesian Network Decision Support: Development and Validation Study

Hill A, Joyner CH, Keith-Jopp C, Yet B, Tuncer Sakar C, Marsh W, Morrissey D

Assessing Serious Spinal Pathology Using Bayesian Network Decision Support: Development and Validation Study

JMIR Form Res 2023;7:e44187

DOI: 10.2196/44187

PMID: 37788068

PMCID: 10582804

Assessing serious spinal pathology using Bayesian Network decision support: development and validation of a prototype tool

  • Adele Hill; 
  • Christopher H Joyner; 
  • Chloe Keith-Jopp; 
  • Barbaros Yet; 
  • Ceren Tuncer Sakar; 
  • William Marsh; 
  • Dylan Morrissey

ABSTRACT

Background:

Identifying and managing serious spinal pathology (SSP), such as cauda equina syndrome or spinal infection, is challenging. Traditional red flag questioning is increasingly criticised, and improving decision-making is being actively researched.

Objective:

We aimed to improve serious pathology identification by constructing and validating a decision support tool using Artificial Intelligence (AI) that combines current evidence and expert knowledge.

Methods:

A modified RAND appropriateness procedure, including variable, structure and probability elicitation was deployed to build a Bayesian AI model of reasoning elicited from 16 experts over 3 rounds. The causal model was designed to predict the likelihood of a patient with a particular presentation having an SSP. An established framework directed a 4-part validation that included comparison of the model with consensus statements, practice guidelines and recent research. Clinical cases were entered into the model and the results compared to clinical judgement from spinal experts.

Results:

The model included 38 variables in three domains of risk factors (10 variables), signs & symptoms (17 variables) and judgement factors (11). Comparison with the evidence showed the model is typically consistent but needs changes to e.g., 2 of 11 judgement factors. Case analysis showed cauda-equina-syndrome, space-occupying-lesion, cancer and inflammatory condition identification performed well across validation domains. Fracture performed less well, but with well-defined reasons for the erroneous results.

Conclusions:

A knowledge-based AI system for decision support for SSP was constructed. The tool can be completed in a time period compatible with a patient contact and shows encouraging validity. Further work to improve the existing model and include treatment decision making is needed alongside prospective validation. The prototype tool is ready to be taken forward for refinement and clinical testing.


 Citation

Please cite as:

Hill A, Joyner CH, Keith-Jopp C, Yet B, Tuncer Sakar C, Marsh W, Morrissey D

Assessing Serious Spinal Pathology Using Bayesian Network Decision Support: Development and Validation Study

JMIR Form Res 2023;7:e44187

DOI: 10.2196/44187

PMID: 37788068

PMCID: 10582804

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.